{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T12:03:47Z","timestamp":1784721827775,"version":"3.55.0"},"reference-count":12,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Background: Pathological N staging remains central to prognostic assessment in colorectal adenocarcinoma; however, it captures nodal disease as an absolute count and does not account for the total number of examined lymph nodes. The lymph node ratio (LNR) may refine postoperative risk stratification by integrating both metastatic nodal burden and lymph node yield. This study evaluated the prognostic value of LNR in a contemporary surgical cohort of patients with colorectal adenocarcinoma. Methods: This retrospective single-center cohort study included consecutive adult patients who underwent surgery for histopathologically confirmed colorectal adenocarcinoma at the Surgical Oncology Clinic of Ankara Bilkent City Hospital between January 2020 and 25 March 2026. Patients with metastatic disease were excluded from the primary curative-intent analysis. LNR was calculated as the number of metastatic lymph nodes divided by the total number of harvested lymph nodes and categorized as 0, 0.01\u20130.20, and &gt;0.20. Overall survival (OS) was calculated from the date of histopathological diagnosis, whereas disease-free survival (DFS) was calculated from the date of curative-intent surgery. Survival outcomes were evaluated using Kaplan\u2013Meier analysis and Cox proportional hazards regression. Results: Among 309 screened patients, 274 non-metastatic patients constituted the final analytic cohort. LNR categories were LNR 0 in 159 patients (58.0%), LNR 0.01\u20130.20 in 76 patients (27.7%), and LNR &gt; 0.20 in 39 patients (14.2%). Median observed follow-up was 24.1 months [IQR, 13.9\u201335.8] for OS and 22.4 months [IQR, 10.8\u201334.3] for DFS. During follow-up, 60 deaths and 90 DFS events occurred. Three-year OS was 76.4%, 71.5%, and 53.4% across the three LNR groups, respectively (log-rank p = 0.014), whereas 3-year DFS was 74.7%, 62.4%, and 9.6%, respectively (log-rank p &lt; 0.001). In multivariable analysis, LNR &gt; 0.20 remained independently associated with impaired DFS (adjusted HR 4.84 (95% CI 2.77\u20138.46); p &lt; 0.001), whereas its association with OS was attenuated after adjustment. Conclusions: In patients undergoing surgery for non-metastatic colorectal adenocarcinoma, LNR &gt; 0.20 identifies a high-risk subgroup with markedly impaired disease-free survival. LNR may complement conventional N staging and improve postoperative recurrence-risk stratification using information already available in routine pathology reports.<\/jats:p>","DOI":"10.3390\/jcm15145743","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T10:48:28Z","timestamp":1784717308000},"page":"5743","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Proportional Nodal Burden as a Marker of Recurrence Risk in Non-Metastatic Colorectal Adenocarcinoma: The Prognostic Role of Lymph Node Ratio"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2432-7334","authenticated-orcid":false,"given":"Adem","family":"Ozcan","sequence":"first","affiliation":[{"name":"Department of Surgical Oncology, Ankara Bilkent City Hospital, 06800 Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5761-4052","authenticated-orcid":false,"given":"Gizem","family":"Gunes","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Ankara Bilkent City Hospital, 06800 Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"ref_1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/DCR.0000000000002323","article-title":"The American Society of Colon and Rectal Surgeons clinical practice guidelines for the management of colon cancer","volume":"65","author":"Vogel","year":"2022","journal-title":"Dis. Colon Rectum"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1200\/JCO.21.02538","article-title":"Adjuvant therapy for stage II colon cancer: ASCO guideline update","volume":"40","author":"Baxter","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13000-024-01449-6","article-title":"Lymph node ratio is a more robust predictor of overall survival than N stage in stage III colorectal adenocarcinoma","volume":"19","author":"Beirat","year":"2024","journal-title":"Diagn. Pathol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"17689","DOI":"10.1038\/s41598-024-68576-4","article-title":"The effect of lymph node ratio on the surgical outcomes in patients with colorectal cancer","volume":"14","author":"Hai","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Li, Y., Wu, G., Zhang, Y., Han, B., Yang, W., Wang, X., Duan, L., Niu, L., Chen, J., and Zhou, W. (2022). Log odds of positive lymph nodes as a novel prognostic predictor for colorectal cancer: A systematic review and meta-analysis. BMC Cancer, 22.","DOI":"10.1186\/s12885-022-09390-x"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1177\/00031348231209532","article-title":"Lymph node ratio as a predictor of survival for colon cancer: A systematic review and meta-analysis","volume":"90","author":"Ichhpuniani","year":"2024","journal-title":"Am. Surg."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.21037\/atm-21-3170","article-title":"Screening and validation of a novel T stage-lymph node ratio classification for operable colon cancer","volume":"9","author":"Pei","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Yang, Y., Wang, Y., and Wang, Z. (2022). Construction of a new clinical staging system for colorectal cancer based on the lymph node ratio: A validation study. Front. Surg., 9.","DOI":"10.3389\/fsurg.2022.929576"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Arrichiello, G., Pirozzi, M., Facchini, B.A., Facchini, S., Paragliola, F., Nacca, V., Nicastro, A., Canciello, M.A., Orlando, A., and Caterino, M. (2022). Beyond N staging in colorectal cancer: Current approaches and future perspectives. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.937114"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Mroczkowski, P., Kim, S., Otto, R., Lippert, H., Zajdel, R., Zajdel, K., and Merecz-Sadowska, A. (2024). Prognostic value of metastatic lymph node ratio and identification of factors influencing the lymph node yield in patients undergoing curative colon cancer resection. Cancers, 16.","DOI":"10.3390\/cancers16010218"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Lin, Z., Li, X., Song, J., Zheng, R., Chen, C., Li, A., and Xu, B. (2022). The Effect of Lymph Node Harvest on Prognosis in Locally Advanced Middle-Low Rectal Cancer After Neoadjuvant Chemoradiotherapy. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.816485"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/14\/5743\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T11:30:01Z","timestamp":1784719801000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/14\/5743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":12,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["jcm15145743"],"URL":"https:\/\/doi.org\/10.3390\/jcm15145743","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]}}}